// App-Quantinova.ai

485 : Blood-based profiling of patients with NSCLC using CLIA certified cell-free DNA tests for EGFR, KRAS and BRAF point mutations and test use in clinical practice

Researchers

Presenter

  • Hestia Mellert

Principal Investigators

  • Scott Thurston

  • Trudi Foreman

  • Westen Hahn

  • Nicholas Dupuis

  • Gary Pestano

Medical Centers

  • Biodesix, Boulder, CO

Locations

  • United States

Companies

  • Biodesix, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Epidermal growth factor receptor

  • KRAS proto-oncogene, GTPase

  • Threonine at amino acid position 790

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved